Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 14(1): 3935, 2024 02 16.
Artigo em Inglês | MEDLINE | ID: mdl-38366055

RESUMO

Deficits in facial emotion recognition have frequently been established in temporal lobe epilepsy (TLE). However, static, rather than dynamic emotion recognition paradigms have been applied. Affective prosody has been insufficiently studied in TLE, and there is a lack of studies investigating associations between auditory and visual emotion recognition. We wished to investigate potential deficits in a dynamic morph task of facial emotion recognition and in an affective prosody recognition task, as well as associations between both tasks. 25 patients with TLE and 24 healthy controls (CG) performed a morph task with faces continuously changing in their emotional intensity. They had to press a button, as soon as they were able to recognize the emotion expressed, and label it accordingly. In the auditory task, subjects listened to neutral sentences spoken in varying emotional tones, and labeled the emotions. Correlation analyses were conducted across both tasks. TLE patients showed significantly reduced prosody recognition compared to CG, and in the morph task, there was a statistical trend towards significantly reduced performance for TLE. Recognition rates in both tasks were significantly associated. TLE patients show deficits in affective prosody recognition, and they may also be impaired in a morph task with dynamically changing facial expressions. Impairments in basic social-cognitive tasks in TLE seem to be modality-independent.


Assuntos
Epilepsia do Lobo Temporal , Reconhecimento Facial , Humanos , Epilepsia do Lobo Temporal/psicologia , Reconhecimento Psicológico , Emoções , Expressão Facial
2.
Epilepsia ; 65(3): 630-640, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38135903

RESUMO

OBJECTIVE: Cenobamate, a novel antiseizure medication with a dual mechanism of action, has been shown in pivotal trials to significantly improve seizure control in treatment-resistant focal epilepsy. We aimed to evaluate whether these promising results could be confirmed in a real-world setting with a follow-up period of up to 12 months. METHODS: Patients from a tertiary epilepsy center who received cenobamate add-on between June 2021 and October 2023 were followed up prospectively at 3, 6, and 12 months after treatment initiation for assessment of seizure outcomes and treatment-related adverse events. RESULTS: The clinical cohort included 112 adult patients with 30% nonlesional cases and a wide spectrum of epileptogenic lesions underlying refractory focal epilepsy. We observed a significant reduction in monthly seizure frequency of all seizure types already after 3 months of treatment at a median cenobamate dose of 100 mg/day. Forty-six percent of patients were responders with a ≥50% seizure reduction, 26% had a ≥75% seizure reduction, and 9% became seizure-free. Among the 74 patients with available follow-up of 12 months, the responder rates reached 55%, 35%, and 19% for ≥50%, ≥75%, and 100% seizure reduction, respectively. After 3 months of treatment, 38% of patients reported adverse effects, mainly (84%) mild to moderate in intensity. Adjustment of comedication allowed successful management of adverse effects in 32% of patients. At a group level, there was no correlation between the cenobamate daily dose and the incidence of adverse events. SIGNIFICANCE: We found a clinically relevant response to cenobamate already at a low daily dose of 100 mg also in a patient cohort with a higher degree of drug resistance than in pivotal trials. Our prospectively collected data provide real-world evidence for high efficacy and good tolerability of the drug, although no standardized treatment protocol or comparison with a control group was applied.


Assuntos
Carbamatos , Clorofenóis , Epilepsia Resistente a Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Epilepsias Parciais , Tetrazóis , Adulto , Humanos , Anticonvulsivantes/uso terapêutico , Quimioterapia Combinada , Epilepsias Parciais/tratamento farmacológico , Convulsões/tratamento farmacológico , Epilepsia Resistente a Medicamentos/tratamento farmacológico , Epilepsia Resistente a Medicamentos/induzido quimicamente , Resultado do Tratamento
3.
PLoS One ; 18(8): e0289574, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37535576

RESUMO

Complex patterns of acoustic communication exist throughout the animal kingdom, including underwater. The river-dwelling and the Pachón cave-adapted morphotypes of the fish Astyanax mexicanus are soniferous and share a repertoire of sounds. Their function and significance is mostly unknown. Here, we explored whether and how sounds produced by blind cavefishes inhabiting different Mexican caves may vary. We compared "Clicks" and "Serial Clicks" produced by cavefish in six different caves distributed in three mountain ranges in Mexico. We also sampled laboratory-bred cavefish lines originating from four of these caves. Sounds were extracted and analyzed using both a manual method and a machine learning-based automation tool developed in-house. Multi-parametric analyses suggest wild cave-specific acoustic signatures, or "accents". An acoustic code also existed in laboratory cavefish lines, suggesting a genetic basis for the evolution of this trait. The variations in acoustic parameters between caves of origin did not seem related to fish phenotypes, phylogeography or ecological conditions. We propose that the evolution of such acoustic signatures would progressively lead to the differentiation of local accents that may prevent interbreeding and thus contribute to speciation.


Assuntos
Cavernas , Characidae , Animais , México , Characidae/genética , Filogeografia , Acústica , Evolução Biológica
4.
Seizure ; 100: 95-102, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35816818

RESUMO

BACKGROUND: Eye-movement patterns during facial emotion recognition are under-researched in patients with focal epilepsy (PWFE). Previous studies including other neurological patients indicate that bilateral mesiotemporal damage could be associated with impaired emotion recognition and abnormal eye-movement patterns. AIMS: The current study addresses the question whether PWFE, in whom fronto-(mesio-)temporal networks are often disturbed, also show abnormal eye-movement patterns during facial emotion recognition. METHOD: 24 PWFE and a group of 29 healthy controls (HC) performed a facial emotion recognition task and a gender recognition task while eye movements were recorded with an eye-tracker. For this purpose, Areas of Interest (AOI) were defined in the presented faces: the eye region and the mouth region. In addition to the proportion of correctly recognized emotions, the following eye-tracking parameters were recorded: Relative fixation duration (FD)/fixation count (FC) in the mouth region/eye region (relative to the FD/FC on the entire screen). RESULTS: PFWE showed an emotion recognition deficit compared to HC, whereas gender recognition performance did not differ between groups. In addition, PWFE showed significantly fewer and shorter fixations in the mouth region than HC, in both the emotion recognition task and the gender recognition task. CONCLUSIONS: When looking at faces, PFWE show eye-movement patterns different from those of healthy controls. Behaviorally, PWFE are only impaired in emotion recognition. Hence, PWFE possibly scan facial regions that are relevant to successful emotion recognition more diffusely and less efficiently than healthy control subjects. Future studies should investigate the etiology of such abnormal eye-movement patterns in PWFE.


Assuntos
Epilepsias Parciais , Reconhecimento Facial , Emoções , Movimentos Oculares , Expressão Facial , Humanos , Reconhecimento Psicológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...